Login to Your Account

France Roundup

DBV Technologies Raises €6M in Series B Financing

By James Etheridge

Wednesday, January 28, 2009

No Abstract


BioWorld International Correspondent

PARIS - DBV Technologies, which specializes in the diagnosis and treatment of allergies, completed a series B financing in which it raised €6 million (US$7.9 million) from one new and one existing investor.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription